???????Stellenbosch 肆客足球 Immunology Research Group
Publications
2011
Mkhize-Kwitshana ZL, Taylor M, Jooste P, Mabaso ML, Walzl G. BMC Infect Dis. 2011 Oct 14;11:273. doi: 10.1186/1471-2334-11-273
http://www.biomedcentral.com/1471-2334/11/273
Kleynhans L, Du Plessis N, Black GF, Loxton AG, Kidd M, van Helden PD, Walzl G, Ronacher K. PLoS One. 2011;6(9):e24639
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024639
Honeyborne I, McHugh TD, Phillips PP, Bannoo S, Bateson A, Carroll N, Perrin FM, Ronacher K, Wright L, van Helden PD, Walzl G, Gillespie SH. J Clin Microbiol. 2011 Nov;49(11):3905
http://jcm.asm.org/content/early/2011/09/07/JCM.00547-11
4. Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.
Matthews K, Wilkinson KA, Kalsdorf B, Roberts T, Diacon A, Walzl G, Wolske J, Ntsekhe M, Syed F, Russell J, Mayosi BM, Dawson R, Dheda K, Wilkinson RJ, Hanekom WA, Scriba TJ. Tuberculosis (Edinb). 2011 Nov;91(6):587-93
http://www.ncbi.nlm.nih.gov/pubmed/21767990
5. Tuberculosis assays: past, present and future.
Chegou NN, Hoek KG, Kriel M, Warren RM, Victor TC, Walzl G. Expert Rev Anti Infect Ther. 2011 Apr;9(4):457-69
http://www.ncbi.nlm.nih.gov/pubmed/21504402
6. Immunological biomarkers of tuberculosis.
Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Nat Rev Immunol. 2011 May;11(5):343-54
http://www.ncbi.nlm.nih.gov/pubmed/21475309
Visser ME, Grewal HM, Swart EC, Dhansay MA, Walzl G, Swanevelder S, Lombard C, Maartens G. Am J Clin Nutr. 2011 Jan;93(1):93-100
http://www.ncbi.nlm.nih.gov/pubmed/21068353
8. Human gene expression profiles of susceptibility and resistance in tuberculosis.
Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G, Walzl G, Kaufmann SH. Genes Immun. 2011 Jan;12(1):15-22
http://www.ncbi.nlm.nih.gov/pubmed/20861863
9. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome.
Tadokera R, Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, Seldon R, Chegou NN, Maartens G, Rangaka MX, Rebe K, Walzl G, Wilkinson RJ. Eur Respir J. 2011 May;37(5):1248-59
http://www.ncbi.nlm.nih.gov/pubmed/20817712
10. Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients.
Jacobsen M, Repsilber D, Kleinsteuber K, Gutschmidt A, Schommer-Leitner S, Black G, Walzl G, Kaufmann SH. Clin Microbiol Infect. 2011 Sep;17(9):1323-31
http://www.ncbi.nlm.nih.gov/pubmed/20673263?